Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer-Reference-Cited by-同舟云学术

Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer

Published:2011-04-08 Issue:7 Volume:25 Page:2433-2446
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Vaneycken Ilse¹,Devoogdt Nick¹,Van Gassen Naomi²³,Vincke Cécile²³,Xavier Catarina¹,Wernery Ulrich⁴,Muyldermans Serge²³,Lahoutte Tony¹⁵,Caveliers Vicky¹⁵

Affiliation:

1. In Vivo Cellular and Molecular Imaging (ICMI) LaboratoryBrusselsBelgium

2. Laboratory of Cellular and Molecular ImmunologyVrije Universiteit Brussel (VUB)BrusselsBelgium

3. Department of Molecular and Cellular InteractionsVlaams Instituut voor Biotechnologie (VIB)BrusselsBelgium

4. Central Veterinary Research LaboratoryDubaiUnited Arab Emirates

5. Nuclear Medicine DepartmentUniversitair Ziekenhuis (UZ) BrusselBrusselsBelgium

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.10-180331

Reference34 articles.

1. Cancer incidence and mortality in Europe, 2004

2. From Bench to Bedside with Targeted Therapies

3. Biology of HER2 and Its Importance in Breast Cancer

4. HER2+ Breast Cancer

5. Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plug-and-play nucleic acid-mediated multimerization of biparatopic nanobodies for molecular imaging;Molecular Therapy - Nucleic Acids;2024-09

2. Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo;Nuclear Medicine and Biology;2024-09

3. Reprogramming Tumor Microenvironment with Precise Photothermal Therapy by Calreticulin Nanobody-Engineered Probiotics;Biomaterials;2024-09

4. Single domain antibody: Development and application in biotechnology and biopharma;Immunological Reviews;2024-08-21

5. Dual‐Targeting of the HER2 Cancer Receptor with an Antibody‐Directed Enzyme and a Nanobody‐Guided MMAE Prodrug Scaffold;ChemBioChem;2024-08-20